Ofori-Asenso Richard
Research Unit, Health Policy Consult, P.O. Box WJ 537, Weija-Accra, Ghana.
Medicines (Basel). 2017 Jun 14;4(2):40. doi: 10.3390/medicines4020040.
Antimicrobial resistance is a major global health issue that has the potential to reverse the substantial progress made against infectious diseases over the past several decades. We need strategic measures to deal with this challenge, including an intensification of public funding for research into anti-microbial agents and their alternatives, stricter mechanisms to minimize antimicrobial misuse within both clinical and non-clinical settings, and support for the development of country-level initiatives. Only with sustained, concerted, and coordinated global efforts are we likely to overcome the current and future challenges posed by these emerging "superbugs".
抗菌药物耐药性是一个重大的全球健康问题，有可能使过去几十年来在抗击传染病方面取得的重大进展发生逆转。我们需要采取战略措施来应对这一挑战，包括加大对抗菌药物及其替代品研究的公共资金投入，在临床和非临床环境中建立更严格的机制以尽量减少抗菌药物的滥用，以及支持各国开展相关行动。只有通过持续、协调一致的全球努力，我们才有可能战胜这些新出现的“超级细菌”带来的当前及未来挑战。
